Literature DB >> 28631037

Inclusion bodies of aggregated hemosiderins in liver macrophages.

Hisao Hayashi1, Yasuaki Tatsumi2, Shinya Wakusawa3, Ryota Shigemasa3, Ryoji Koide3, Ken-Ichi Tsuchida4, Natsuko Morotomi5, Tetsuji Yamashita6, Kotaro Kumagai7, Yukiya Ono8, Kazuhiko Hayashi8, Masatoshi Ishigami8, Hidemi Goto8, Ayako Kato2, Koichi Kato2.   

Abstract

Hemosiderin formation is a structural indication of iron overload. We investigated further adaptations of the liver to excess iron. Five patients with livers showing iron-rich inclusions larger than 2 µm were selected from our database. The clinical features of patients and structures of the inclusions were compared with those of 2 controls with mild iron overload. All patients had severe iron overload with more than 5000 ng/mL of serum ferritin. Etiologies were variable, from hemochromatosis to iatrogenic iron overload. Their histological stages were either portal fibrosis or cirrhosis. Inclusion bodies were ultra-structurally visualized as aggregated hemosiderins in the periportal macrophages. X-ray analysis always identified, in addition to a large amount of iron complexes including oxygen and phosphorus, a small amount of copper and sulfur in the mosaic matrixes of inclusions. There were no inclusions in the control livers. Inclusion bodies, when the liver is loaded with excess iron, may appear in the macrophages as isolated organella of aggregated hemosiderins. Trace amounts of copper-sulfur complexes were always identified in the mosaic matrices of the inclusions, suggesting cuproprotein induction against excess iron. In conclusion, inclusion formation in macrophages may be an adaptation of the liver loaded with excess iron.

Entities:  

Keywords:  Copper; Hemochromatosis; Hemosiderin; Iron; Liver; Macrophage

Mesh:

Substances:

Year:  2017        PMID: 28631037     DOI: 10.1007/s00795-017-0163-x

Source DB:  PubMed          Journal:  Med Mol Morphol        ISSN: 1860-1499            Impact factor:   2.309


  26 in total

Review 1.  Enzyme therapy for Pompe disease: from science to industrial enterprise.

Authors:  Arnold J J Reuser; Hannerieke Van Den Hout; Agnes G A Bijvoet; Marian A Kroos; Martin P Verbeet; Ans T Van Der Ploeg
Journal:  Eur J Pediatr       Date:  2002-08-13       Impact factor: 3.183

2.  FERRITIN AND APOFERRITIN.

Authors:  S Granick; L Michaelis
Journal:  Science       Date:  1942-04-24       Impact factor: 47.728

3.  Experiments on the solubility of hemosiderin in acids and other reagents during and after various fixations.

Authors:  R D Lillie
Journal:  Am J Pathol       Date:  1939-03       Impact factor: 4.307

Review 4.  Metabolic crossroads of iron and copper.

Authors:  James F Collins; Joseph R Prohaska; Mitchell D Knutson
Journal:  Nutr Rev       Date:  2010-03       Impact factor: 7.110

Review 5.  Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment.

Authors:  Antonello Pietrangelo
Journal:  Gastroenterology       Date:  2010-06-11       Impact factor: 22.682

6.  The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis.

Authors:  Adriana Donovan; Christine A Lima; Jack L Pinkus; Geraldine S Pinkus; Leonard I Zon; Sylvie Robine; Nancy C Andrews
Journal:  Cell Metab       Date:  2005-03       Impact factor: 27.287

Review 7.  The role of lysosomes in iron metabolism and recycling.

Authors:  Tino Kurz; John W Eaton; Ulf T Brunk
Journal:  Int J Biochem Cell Biol       Date:  2011-09-03       Impact factor: 5.085

Review 8.  Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation.

Authors:  Tomas Ganz
Journal:  Blood       Date:  2003-03-27       Impact factor: 22.113

9.  Genetic background of Japanese patients with adult-onset storage diseases in the liver.

Authors:  Hisao Hayashi; Shinya Wakusawa; Motoyoshi Yano; Toshihide Okada
Journal:  Hepatol Res       Date:  2007-05-22       Impact factor: 4.288

10.  Copper Accumulates in Hemosiderins in Livers of Patients with Iron Overload Syndromes.

Authors:  Yukiya Ono; Masatoshi Ishigami; Kazuhiko Hayashi; Shinya Wakusawa; Hisao Hayashi; Kotaro Kumagai; Natsuko Morotomi; Tetsuji Yamashita; Miwa Kawanaka; Minemori Watanabe; Hiroaki Ozawa; Mayumi Tai; Hiroaki Miyajima; Kentarou Yoshioka; Yoshiki Hirooka; Hidemi Goto
Journal:  J Clin Transl Hepatol       Date:  2015-06-15
View more
  2 in total

1.  Hepatic Macrophage Abundance and Phenotype in Aging and Liver Iron Accumulation.

Authors:  Steven A Bloomer
Journal:  Int J Mol Sci       Date:  2022-06-10       Impact factor: 6.208

2.  Low oxygen: A (tough) way of life for Okavango fishes.

Authors:  Thea M Edwards; Ineelo J Mosie; Brandon C Moore; Guy Lobjoit; Kelsie Schiavone; Robert E Bachman; Mike Murray-Hudson
Journal:  PLoS One       Date:  2020-07-30       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.